A ribonuclease protection assay-based approach for analysis of angiogenic gene expression in archival tissues

Diagnostic Molecular Pathology

Volumn 16, Issue 3, 2007, Pages 147-152

  Naldini, Antonella ^a   Ardinghi, Camilla ^a   Massi, Daniela ^b   Santucci, Marco ^b   Franchi, Alessandro ^b   Tarantini, Francesca ^b   Geppetti, Pierangelo ^b   Cirino, Giuseppe ^c   Carraro, Fabio ^a  

^a UNIVERSITY OF SIENA   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Angiogenesis; Archival tissues; Gene expression; Ribonuclease protection assay; RNA

Indexed keywords

ANGIOPOIETIN RECEPTOR; RNA; TIE 1 RECEPTOR; VASCULOTROPIN RECEPTOR 1;

ANGIOGENESIS; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MELANOMA; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RIBONUCLEASE PROTECTION ASSAY; RNA EXTRACTION; RNA ISOLATION;

BIOLOGICAL SPECIMEN BANKS; FORMALDEHYDE; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMANS; IMMUNOHISTOCHEMISTRY; MELANOMA; NEOVASCULARIZATION, PATHOLOGIC; NUCLEIC ACID AMPLIFICATION TECHNIQUES; PARAFFIN EMBEDDING; RIBONUCLEASES; RNA, MESSENGER; SKIN DISEASES; SKIN NEOPLASMS; TISSUE FIXATION;

EID: 34548208311     PISSN: 10529551     EISSN: None     Source Type: Journal    
DOI: 10.1097/PDM.0b013e31803c5576     Document Type: Article

References (23)

1. Hirschhorn JN. Genetic approaches to studying common diseases and complex traits. Pediatr Res. 2005;57:74R-77R.
2. Espina V, Geho D, Mehta AI, et al. Pathology of the future: molecular profiling for targeted therapy. Cancer Invest. 2005;23:36-46.
3. Mizuno T, Nagamura H, Iwamoto KS, et al. RNA from decades-old archival tissue blocks for retrospective studies. Diagn Mol Pathol. 1998;7:202-208.
4. Klimecki WT, Futscher BW, Dalton WS. Effects of ethanol and paraformaldehyde on RNA yield and quality. Biotechniques. 1994;16:1021-1023.
5. Masuda N, Ohnishi T, Kawamoto S, et al. Analysis of chemical modification of RNA from formalin-fixed samples and optimization of molecular biology applications for such samples. Nucleic Acids Res. 1999;27:4436-4443.
6. Goldsworthy SM, Stockton PS, Trempus CS, et al. Effects of fixation on RNA extraction and amplification from laser capture microdissected tissue. Mol Carcinog. 1999;25:86-91.
7. Bustin SA. Quantification of mRNA using real-time reverse transcription PCR (RT-PCR): trends and problems. J Mol Endocrinol. 2002;29:23-39.
8. Koch I, Slotta-Huspenina J, Hollweck R, et al. Real-time quantitative RT-PCR shows variable, assay-dependent sensitivity to formalin fixation: implications for direct comparison of transcript levels in paraffin-embedded tissues. Diagn Mol Pathol. 2006;15:149-156.
9. Muller K, Ehlers S, Solbach W, et al. Novel multi-probe RNase protection assay (RPA) sets for the detection of murine chemokine gene expression. J Immunol Methods. 2001;249:155-165.
10. Ribatti D, Vacca A, Nico B, et al. Angiogenesis: basic and clinical aspects. Ital J Anat Embryol. 2003;108:1-24.
11. Guedez L, Rivera AM, Salloum R, et al. Quantitative assessment of angiogenic responses by the directed in vivo angiogenesis assay. Am J Pathol. 2003;162:1431-1439.
12. Shih SC, Robinson GS, Perruzzi CA, et al. Molecular profiling of angiogenesis markers. Am J Pathol. 2002;161:35-41.
13. Sobel ME. Ethical issues in molecular pathology: paradigms in flux. Arch Pathol Lab Med. 1999;123:1076-1078.
14. Naldini A, Carraro F. Hypoxia modulates cyclin and cytokine expression and inhibits peripheral mononuclear cell proliferation. J Cell Physiol. 1999;181:448-454.
15. Specht K, Richter T, Muller U, et al. Quantitative gene expression analysis in microdissected archival formalin-fixed and paraffin-embedded tumor tissue. Am J Pathol. 2001;158:419-429.
16. Belin D. The RNase protection assay. Methods Mol Biol. 1996;58:131-136.
17. Gitay-Goren H, Halaban R, Neufeld G. Human melanoma cells but not normal melanocytes express vascular endothelial growth factor receptors. Biochem Biophys Res Commun. 1993;190:702-708.
18. Straume O, Akslen LA. Expression of vascular endothelial growth factor, its receptors (FLT-1, KDR) and TSP-1 related to microvessel density and patient outcome in vertical growth phase melanomas. Am J Pathol. 2001;159:223-235.
19. Graells J, Vinyals A, Figueras A, et al. Overproduction of VEGF concomitantly expressed with its receptors promotes growth and survival of melanoma cells through MAPK and PI3K signaling. J Invest Dermatol. 2004;123:1151-1161.
20. Clarijs R, Schalkwijk L, Hofmann UB, et al. Induction of vascular endothelial growth factor receptor-3 expression on tumor microvasculature as a new progression marker in human cutaneous melanoma. Cancer Res. 2002;62:7059-7065.
21. Hendrix MJ, Seftor EA, Meltzer PS, et al. Expression and functional significance of VE-cadherin in aggressive human melanoma cells: role in vasculogenic mimicry. Proc Natl Acad Sci U S A. 2001;98:8018-8023.
22. Siemeister G, Schirner M, Weindel K, et al. Two independent mechanisms essential for tumor angiogenesis: inhibition of human melanoma xenograft growth by interfering with either the vascular endothelial growth factor receptor pathway or the Tie-2 pathway. Cancer Res. 1999;59:3185-3191.
23. Tellez C, Bar-Eli M. Role and regulation of the thrombin receptor (PAR-1) in human melanoma. Oncogene. 2003;22:3130-3137.